Assessment of Adductor Canal Blockade in Anterior Cruciate Ligament Surgery

NCT ID: NCT02419261

Last Updated: 2018-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assessment of sensory and motor blockade of adductor canal blockade performed for anterior cruciate ligament repair in comparison with femoral nerve blockade.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The adductor canal blockade is a reliable technique for analgesia after knee surgery. It is a safe technique, avoiding muscle weakness, and by this way limiting the risk of fall. Injection of local anaesthetics in the adductor canal does not block the sole saphenous nerve. Demonstration of a proximal spreading, around the branches of the femoral nerve have been made. The aim of this study is to assess a possible spreading from the adductor to the the popliteal fossa, where sciatic nerve and its branches are located. Pinprick test all around the knee and the leg, combined with motor assessment of the muscle of the leg and the ankle will be realised. This assessment was compared with femoral nerve blockade, classically used for analgesia after this kind of surgery (anterior cruciate ligament repair)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery of Arthroscopic Anterior Cruciate Ligament Repair

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adductor Canal Blockade

In this group, patient will benefit of an ultrasound guided adductor canal blockade (20 ml of Ropivacaine 0.75%) as analgesic nerve blockade for their surgery of anterior cruciate ligament repair

Group Type ACTIVE_COMPARATOR

Analgesic nerve blockade (Ropivacaine)

Intervention Type DRUG

Analgesic nerve blockade for Arthroscopic surgical repair of the anterior cruciate ligament

Arthroscopic surgical repair of the anterior cruciate ligament

Intervention Type PROCEDURE

Femoral Nerve Blockade

In this group, patient will benefit of an ultrasound guided femoral nerve blockade (20 ml of Ropivacaine 0.75%) as analgesic nerve blockade for their surgery of anterior cruciate ligament repair

Group Type ACTIVE_COMPARATOR

Analgesic nerve blockade (Ropivacaine)

Intervention Type DRUG

Analgesic nerve blockade for Arthroscopic surgical repair of the anterior cruciate ligament

Arthroscopic surgical repair of the anterior cruciate ligament

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Analgesic nerve blockade (Ropivacaine)

Analgesic nerve blockade for Arthroscopic surgical repair of the anterior cruciate ligament

Intervention Type DRUG

Arthroscopic surgical repair of the anterior cruciate ligament

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients scheduled for anterior cruciate ligament repair

Exclusion Criteria

* Refusal to study,
* coagulation disorder,
* infection at the puncture site,
* preexisting neuropathy,
* allergy to local anesthetics,
* renal or hepatocellular insufficiency,
* context of chronic pain,
* drugs abuse,
* pregnant patient
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Liege

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

J P Lecoq

MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Pierre H Lecoq, MD PhD

Role: PRINCIPAL_INVESTIGATOR

University of Liege, University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Liege, University Hospital

Liège, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-Pierre H Lecoq, MD PhD

Role: CONTACT

003243667180

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jean-Pierre H Lecoq, MD PhD

Role: primary

003243667180

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Gauthier - Lecoq - Goffin

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adductor Canal Block
NCT04513145 ACTIVE_NOT_RECRUITING PHASE2/PHASE3
High Versus Low Adductor Canal Block
NCT04155983 UNKNOWN PHASE4